γ2-Melanocyte stimulation hormone (γ2- MSH) truncation studies results in the cautionary note that γ2- MSH is not selective for the mouse MC3R over the mouse MC5R

Christine G. Joseph, Hua Yao, Joseph W. Scott, Nicholas B. Sorensen, Rebecca N. Marnane, Kathleen G. Mountjoy, Carrie Haskell-Luevano

Research output: Contribution to journalArticle

Abstract

The melanocortin system has been implicated in a multitude of physiological pathways including obesity, satiety, energy homeostasis, sexual behavior, pigmentation, sodium regulation, hypertension, and many others. Based upon studies of the endogenous melanocortin receptor agonists at the cloned human melanocortin receptor proteins, it was concluded that the γ-MSH related agonist ligands are selective for the MC3 versus the MC4 and MC5 receptors. In attempts to understand and identify the specific amino acids of γ2-MSH important for MC3R selectivity, we have performed N- and C-terminal truncation studies and pharmacologically characterized twenty-eight ligands at the mouse MC1 and MC3-5 melanocortin receptors. The C-terminal Trp-Asp9-Arg10-Phe11 residues are important for nM potency at the mMC3R and the Arg7-Trp8 residues are important for mMC5R nM potency. We observed the unanticipated results that several of the C-terminal truncated analogs possessed nM agonist potency at the mMC3 and mMC5Rs which lead us to perform a comparative side-by-side study of the mouse and human MC5R. These data resulted in μM γ2-MSH analog potency at the hMC5R, consistent with previous reports, however at the mMC5R, nM γ2-MSH analog potency was observed. Thus, these data support the hypothesis of important species specific differences in γ-MSH related ligand potency at the rodent versus human MC5R subtype that is critical for the interpretation of in vivo rodent physiological studies. These results prompted us to examine the affects of a peripherally administered melanocortin agonist on hypothalamic gene expression levels of the MC3R, MC4R, and MC5R. The super potent non-selective NDP-MSH agonist was administered i.p. and resulted in significantly decreased levels of mMC3R and mMC5R hypothalamic mRNA versus saline control. These data provide for the first time data demonstrating peripherally administered NDP-MSH can modify hypothalamic melanocortin receptor expression levels.

Original languageEnglish (US)
Pages (from-to)2304-2313
Number of pages10
JournalPeptides
Volume31
Issue number12
DOIs
StatePublished - Dec 2010
Externally publishedYes

Fingerprint

Melanocyte-Stimulating Hormones
Melanocytes
Melanocortin Receptors
Hormones
Melanocortins
Ligands
Rodentia
Receptor, Melanocortin, Type 4
Pigmentation
Gene expression
Sexual Behavior
Homeostasis
Obesity
Sodium
Hypertension
Gene Expression
Amino Acids
Messenger RNA
Proteins

Keywords

  • Blood pressure
  • GPCR
  • Heart
  • Melanotropin
  • Obesity
  • Receptor brain expression

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

γ2-Melanocyte stimulation hormone (γ2- MSH) truncation studies results in the cautionary note that γ2- MSH is not selective for the mouse MC3R over the mouse MC5R. / Joseph, Christine G.; Yao, Hua; Scott, Joseph W.; Sorensen, Nicholas B.; Marnane, Rebecca N.; Mountjoy, Kathleen G.; Haskell-Luevano, Carrie.

In: Peptides, Vol. 31, No. 12, 12.2010, p. 2304-2313.

Research output: Contribution to journalArticle

Joseph, Christine G. ; Yao, Hua ; Scott, Joseph W. ; Sorensen, Nicholas B. ; Marnane, Rebecca N. ; Mountjoy, Kathleen G. ; Haskell-Luevano, Carrie. / γ2-Melanocyte stimulation hormone (γ2- MSH) truncation studies results in the cautionary note that γ2- MSH is not selective for the mouse MC3R over the mouse MC5R. In: Peptides. 2010 ; Vol. 31, No. 12. pp. 2304-2313.
@article{94448b1ae50e43ec9a91062631aa8eb3,
title = "γ2-Melanocyte stimulation hormone (γ2- MSH) truncation studies results in the cautionary note that γ2- MSH is not selective for the mouse MC3R over the mouse MC5R",
abstract = "The melanocortin system has been implicated in a multitude of physiological pathways including obesity, satiety, energy homeostasis, sexual behavior, pigmentation, sodium regulation, hypertension, and many others. Based upon studies of the endogenous melanocortin receptor agonists at the cloned human melanocortin receptor proteins, it was concluded that the γ-MSH related agonist ligands are selective for the MC3 versus the MC4 and MC5 receptors. In attempts to understand and identify the specific amino acids of γ2-MSH important for MC3R selectivity, we have performed N- and C-terminal truncation studies and pharmacologically characterized twenty-eight ligands at the mouse MC1 and MC3-5 melanocortin receptors. The C-terminal Trp-Asp9-Arg10-Phe11 residues are important for nM potency at the mMC3R and the Arg7-Trp8 residues are important for mMC5R nM potency. We observed the unanticipated results that several of the C-terminal truncated analogs possessed nM agonist potency at the mMC3 and mMC5Rs which lead us to perform a comparative side-by-side study of the mouse and human MC5R. These data resulted in μM γ2-MSH analog potency at the hMC5R, consistent with previous reports, however at the mMC5R, nM γ2-MSH analog potency was observed. Thus, these data support the hypothesis of important species specific differences in γ-MSH related ligand potency at the rodent versus human MC5R subtype that is critical for the interpretation of in vivo rodent physiological studies. These results prompted us to examine the affects of a peripherally administered melanocortin agonist on hypothalamic gene expression levels of the MC3R, MC4R, and MC5R. The super potent non-selective NDP-MSH agonist was administered i.p. and resulted in significantly decreased levels of mMC3R and mMC5R hypothalamic mRNA versus saline control. These data provide for the first time data demonstrating peripherally administered NDP-MSH can modify hypothalamic melanocortin receptor expression levels.",
keywords = "Blood pressure, GPCR, Heart, Melanotropin, Obesity, Receptor brain expression",
author = "Joseph, {Christine G.} and Hua Yao and Scott, {Joseph W.} and Sorensen, {Nicholas B.} and Marnane, {Rebecca N.} and Mountjoy, {Kathleen G.} and Carrie Haskell-Luevano",
year = "2010",
month = "12",
doi = "10.1016/j.peptides.2010.08.025",
language = "English (US)",
volume = "31",
pages = "2304--2313",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - γ2-Melanocyte stimulation hormone (γ2- MSH) truncation studies results in the cautionary note that γ2- MSH is not selective for the mouse MC3R over the mouse MC5R

AU - Joseph, Christine G.

AU - Yao, Hua

AU - Scott, Joseph W.

AU - Sorensen, Nicholas B.

AU - Marnane, Rebecca N.

AU - Mountjoy, Kathleen G.

AU - Haskell-Luevano, Carrie

PY - 2010/12

Y1 - 2010/12

N2 - The melanocortin system has been implicated in a multitude of physiological pathways including obesity, satiety, energy homeostasis, sexual behavior, pigmentation, sodium regulation, hypertension, and many others. Based upon studies of the endogenous melanocortin receptor agonists at the cloned human melanocortin receptor proteins, it was concluded that the γ-MSH related agonist ligands are selective for the MC3 versus the MC4 and MC5 receptors. In attempts to understand and identify the specific amino acids of γ2-MSH important for MC3R selectivity, we have performed N- and C-terminal truncation studies and pharmacologically characterized twenty-eight ligands at the mouse MC1 and MC3-5 melanocortin receptors. The C-terminal Trp-Asp9-Arg10-Phe11 residues are important for nM potency at the mMC3R and the Arg7-Trp8 residues are important for mMC5R nM potency. We observed the unanticipated results that several of the C-terminal truncated analogs possessed nM agonist potency at the mMC3 and mMC5Rs which lead us to perform a comparative side-by-side study of the mouse and human MC5R. These data resulted in μM γ2-MSH analog potency at the hMC5R, consistent with previous reports, however at the mMC5R, nM γ2-MSH analog potency was observed. Thus, these data support the hypothesis of important species specific differences in γ-MSH related ligand potency at the rodent versus human MC5R subtype that is critical for the interpretation of in vivo rodent physiological studies. These results prompted us to examine the affects of a peripherally administered melanocortin agonist on hypothalamic gene expression levels of the MC3R, MC4R, and MC5R. The super potent non-selective NDP-MSH agonist was administered i.p. and resulted in significantly decreased levels of mMC3R and mMC5R hypothalamic mRNA versus saline control. These data provide for the first time data demonstrating peripherally administered NDP-MSH can modify hypothalamic melanocortin receptor expression levels.

AB - The melanocortin system has been implicated in a multitude of physiological pathways including obesity, satiety, energy homeostasis, sexual behavior, pigmentation, sodium regulation, hypertension, and many others. Based upon studies of the endogenous melanocortin receptor agonists at the cloned human melanocortin receptor proteins, it was concluded that the γ-MSH related agonist ligands are selective for the MC3 versus the MC4 and MC5 receptors. In attempts to understand and identify the specific amino acids of γ2-MSH important for MC3R selectivity, we have performed N- and C-terminal truncation studies and pharmacologically characterized twenty-eight ligands at the mouse MC1 and MC3-5 melanocortin receptors. The C-terminal Trp-Asp9-Arg10-Phe11 residues are important for nM potency at the mMC3R and the Arg7-Trp8 residues are important for mMC5R nM potency. We observed the unanticipated results that several of the C-terminal truncated analogs possessed nM agonist potency at the mMC3 and mMC5Rs which lead us to perform a comparative side-by-side study of the mouse and human MC5R. These data resulted in μM γ2-MSH analog potency at the hMC5R, consistent with previous reports, however at the mMC5R, nM γ2-MSH analog potency was observed. Thus, these data support the hypothesis of important species specific differences in γ-MSH related ligand potency at the rodent versus human MC5R subtype that is critical for the interpretation of in vivo rodent physiological studies. These results prompted us to examine the affects of a peripherally administered melanocortin agonist on hypothalamic gene expression levels of the MC3R, MC4R, and MC5R. The super potent non-selective NDP-MSH agonist was administered i.p. and resulted in significantly decreased levels of mMC3R and mMC5R hypothalamic mRNA versus saline control. These data provide for the first time data demonstrating peripherally administered NDP-MSH can modify hypothalamic melanocortin receptor expression levels.

KW - Blood pressure

KW - GPCR

KW - Heart

KW - Melanotropin

KW - Obesity

KW - Receptor brain expression

UR - http://www.scopus.com/inward/record.url?scp=78049482868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049482868&partnerID=8YFLogxK

U2 - 10.1016/j.peptides.2010.08.025

DO - 10.1016/j.peptides.2010.08.025

M3 - Article

C2 - 20833220

AN - SCOPUS:78049482868

VL - 31

SP - 2304

EP - 2313

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 12

ER -